Sangamo Therapeutics
SGMO
#9355
Rank
ยฃ72.63 M
Marketcap
ยฃ0.20
Share price
5.35%
Change (1 day)
-55.69%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ73.97 Million, an increase over its 2023 earnings that were of -ยฃ89.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million12.34%
2024 -ยฃ73.97 Million-17.27%
2023 -ยฃ89.41 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ97.34 Million23.17%
2019 -ยฃ79.03 Million36.33%
2018 -ยฃ57.97 Million36.89%
2017 -ยฃ42.35 Million-22.32%
2016 -ยฃ54.52 Million54.86%
2015 -ยฃ35.21 Million75.62%
2014 -ยฃ20.05 Million0.13%
2013 -ยฃ20.02 Million
2011 -ยฃ26.92 Million43.66%
2010 -ยฃ18.74 Million28.52%
2009 -ยฃ14.58 Million-23.55%
2008 -ยฃ19.07 Million2.45%
2007 -ยฃ18.62 Million19.5%
2006 -ยฃ15.58 Million50.78%
2005 -ยฃ10.33 Million75%
2004 -ยฃ5.91 Million-33.25%
2003 -ยฃ8.85 Million-62.27%
2002 -ยฃ23.44 Million102.82%
2001 -ยฃ11.56 Million23.21%
2000 -ยฃ9.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ25.20 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.74 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.16 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.89 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.36 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.84 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.43 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.36 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA